Skip to content

Behavior Therapy vs Education for Persistent Headache After Mild TBI

Examining a Novel Treatment for Persistent Headache After Mild Traumatic Brain Injury

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07229391
Enrollment
60
Registered
2025-11-17
Start date
2027-10-01
Completion date
2030-04-01
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Headache

Keywords

Headache, Behavior therapy, Brain Injuries, Traumatic

Brief summary

This study will test a new treatment, called Headache reprocessing, for persistent post-traumatic headache. The new treatment will be compared to a headache education intervention. The main objectives of the study are to examine the feasibility, safety, and clinical appropriateness of the new treatment.

Detailed description

Persistent post-traumatic headache (PPTH) is a common, debilitating health condition affecting Veterans and civilians. Relative to other headache disorders, PPTH is especially severe and impairing. PPTH has no established first-line treatments at this time. This research seeks to develop a new behavioral treatment, called headache reprocessing, to target fear and avoidance behaviors and cognitions, and associated neural changes, that drive PPTH. This trial will test the feasibility, safety, and clinical appropriateness of Headache Reprocessing Therapy by comparing it to a headache education control condition in a randomized controlled trial. We will randomize 60 Veterans with PPTH to take part in this study. Headache reprocessing and the educational control intervention will be delivered in group format over eight sessions (one per week for eight weeks). This intervention has the potential to improve available treatment options for PPTH.

Interventions

BEHAVIORALHeadache reprocessing

Behavior therapy focused on sensations and avoidance behaviors

Education about ways to limit and manage headaches

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Enrolled in healthcare at VA San Diego Healthcare System; 2. History of mild TBI (mTBI), or head injury that is below the diagnostic threshold for mTBI 3. Headache that had its lifetime onset or significantly worsened within 90 days of a concussive event 4. Headache has persisted for at least 90 days since its onset or worsening 5. No changes in past 3 months to medical management of headache or comorbid psychiatric symptoms, and no anticipated changes during the study interval 6. No current participation in psychological intervention for pain or headache

Exclusion criteria

1. History of moderate or severe traumatic brain injury 2. Uncontrolled bipolar, psychotic, or substance use disorder 3. Acute suicidality as determined by screening as high risk or has a history of suicide attempt within the past 1 year; 4. Other factors that would preclude participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Enrollment rateTypically up to 3 months, from initial referral to decision to enroll or notNumber enrolled out of number approached
Attrition12 weeks% of randomized who are lost to follow-up before week 12
AttendanceDuring the 8-week interventionPercent of participants attending 80+% of sessions
Homework completionDuring the 8-week interventionPercent of participants completing 80+% of homework
Credibility/Expectancy QuestionnaireWeek 12Scale measuring how credible the intervention seemed to participants
Client Satisfaction QuestionnaireWeek 12Scale measuring participant satisfaction with the intervention
Adverse events rated to the interventionFull study period (28 weeks)Adverse events determined to be caused by the intervention
Change in Headache Impact Test-6 scoreWeek 0 through Week 12A widely-used scale measuring the impact that headaches have on daily life.

Countries

United States

Contacts

Primary ContactJoel Fishbein
joel.fishbein2@va.gov(858) 642-3870

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026